Skip to main content

Table 1 Demographic and clinical data for the 20 representative patients included in the study

From: High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis

Patient number Age (years) F/M Duration of disease (years) Source of synovial tissue CRP (mg/l) RF DMARDs NSAIDs Corticosteroid
Rheumatoid arthritis patients        
1 32 M 5 TJR, knee joint left 82.7 + + - +
2 49 F 6 Expiration baker cystis, knee joint right 32.5 + + - +
3 73 M 10 TJR, knee joint right 74.8 + - + -
4 65 F 16 TJR, thigh joint right 29.5 ? + + +
5 60 M 9 SE, knee joint right 84.6 + - + -
6 55 F 10 TJR, knee joint right 62.2 - - + -
7 57 F 10 TJR, knee joint left 17.4 + - + +
8 55 M 10 TJR, knee joint left 49.5 - - + -
9 46 M 8 SE, wrist joint left 15.9 + + - -
10 49 F 12 SE, wrist joint right 40.7 + + + -
Osteoarthritis patients        
1 52 M 2 SE, knee joint left 96.0 - - - -
2 31 F 5 SE, knee joint left 36.0 + - - -
3 37 M 1 SE, knee joint right <5.0 - - - -
4 70 M 5 TJR, knee joint right <5.0 - - + -
5 77 M 8 TJR, knee joint right <5.0 - - + -
6 62 F 16 TJR, knee joint right <5.0 - - + -
7 74 F 20 TJR, knee joint left <5.0 - - + -
8 69 F 10 TJR, knee joint right 12.2 ? - + -
9 71 F 10 TJR, knee joint left 15.9 + - + -
10 67 F 1.5 TJR, knee joint left <5.0 - - + -
  1. CRP, C-reactive protein; DMARD, disease-modifying antirheumatic drug; F/M, female/male; NSAID, nonsteroidal anti-inflammatory drug; RF, rheumatoid factor; SE, synovectomy; TJR, total joint replacement.